263 related articles for article (PubMed ID: 33413835)
41. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
[TBL] [Abstract][Full Text] [Related]
42. Stroke prevention with oral anticoagulation therapy in patients with atrial fibrillation--focus on the elderly.
Lip GY; Lane DA
Circ J; 2013; 77(6):1380-8. PubMed ID: 23657131
[TBL] [Abstract][Full Text] [Related]
43. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
[TBL] [Abstract][Full Text] [Related]
44. Optimal anticoagulation in elderly patients with atrial fibrillation: Which drug at which dose?
Liao JN; Chan YH; Kuo L; Tsai CT; Lim SS; Chao TF
Kardiol Pol; 2022; 80(2):128-136. PubMed ID: 35167115
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the CHA
Yao X; Gersh BJ; Sangaralingham LR; Kent DM; Shah ND; Abraham NS; Noseworthy PA
Am J Cardiol; 2017 Nov; 120(9):1549-1556. PubMed ID: 28844514
[TBL] [Abstract][Full Text] [Related]
46. Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study.
Grymonprez M; De Backer TL; Capiau A; Vauterin D; Mehuys E; Boussery K; Steurbaut S; Lahousse L
Br J Clin Pharmacol; 2023 Apr; 89(4):1360-1373. PubMed ID: 36321924
[TBL] [Abstract][Full Text] [Related]
47. Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry.
Goldhaber SZ; Bassand JP; Camm AJ; Virdone S; Pieper K; Cools F; Corbalan R; Gersh BJ; Goto S; Haas S; Misselwitz F; Parkhomenko A; Steffel J; Stepinska J; Turpie AGG; Verheugt FWA; Kayani G; Kakkar AK;
Am J Med; 2024 Feb; 137(2):128-136.e13. PubMed ID: 37918777
[TBL] [Abstract][Full Text] [Related]
48. Risk of cardiovascular events and incident atrial fibrillation in patients without prior atrial fibrillation: Implications for expanding the indications for anticoagulation.
Yao X; Gersh BJ; Sangaralingham LR; Shah ND; Noseworthy PA
Am Heart J; 2018 May; 199():137-143. PubMed ID: 29754652
[TBL] [Abstract][Full Text] [Related]
49. Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage.
Wu VC; Huang YC; Chen SW; Liu CH; Chang CW; Chen CC; Chang SH; Lin MS; Lee TH; Chen MC; Hsieh IC; Chu PH; Lin YS
Medicine (Baltimore); 2021 Aug; 100(32):e26945. PubMed ID: 34397946
[TBL] [Abstract][Full Text] [Related]
50. Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database.
Mitchell A; Welsh TJ; Watson MC; Snowball J; McGrogan A
BMJ Open; 2019 Dec; 9(12):e032646. PubMed ID: 31843842
[TBL] [Abstract][Full Text] [Related]
51. Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.
Chao TF; Lip GYH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
Eur Heart J; 2019 May; 40(19):1504-1514. PubMed ID: 30605505
[TBL] [Abstract][Full Text] [Related]
52. Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.
Ueberham L; Dagres N; Potpara TS; Bollmann A; Hindricks G
Adv Ther; 2017 Oct; 34(10):2274-2294. PubMed ID: 28956288
[TBL] [Abstract][Full Text] [Related]
53. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
[TBL] [Abstract][Full Text] [Related]
54. Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists.
Konieczyńska M; Sobieraj E; Bryk AH; Dębski M; Polak M; Podolec P; Małecka B; Pająk A; Desteghe L; Heidbuchel H; Undas A
Kardiol Pol; 2018; 76(7):1089-1096. PubMed ID: 29528483
[TBL] [Abstract][Full Text] [Related]
55. Implementation of oral anticoagulation treatment guidelines in patients with newly diagnosed atrial fibrillation.
Arbel A; Abu-Ful Z; Preis M; Cohen S; Saliba W
Br J Clin Pharmacol; 2021 Dec; 87(12):4747-4755. PubMed ID: 33982796
[TBL] [Abstract][Full Text] [Related]
56. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
[TBL] [Abstract][Full Text] [Related]
57. Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.
Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR;
Am J Kidney Dis; 2017 Jun; 69(6):734-743. PubMed ID: 27998624
[TBL] [Abstract][Full Text] [Related]
58. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R
Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595
[TBL] [Abstract][Full Text] [Related]
59. Evidence-Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation.
Schaffer AL; Falster MO; Brieger D; Jorm LR; Wilson A; Hay M; Leeb K; Pearson S; Nasis A
J Am Heart Assoc; 2019 Dec; 8(24):e014287. PubMed ID: 31795822
[TBL] [Abstract][Full Text] [Related]
60. Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease.
Potpara TS; Jokic V; Dagres N; Larsen TB; Lane DA; Hindricks G; Lip GY
Curr Med Chem; 2016; 23(19):2055-69. PubMed ID: 26861000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
